Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Fluorometric Assay from US Patent US11787791: "Inhibitors of VAP-1"
Assay data:94 Active, 91 Activity ≤ 1 µM, 94 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
VAP-1 Assay from US Patent US20230295140: "INHIBITORS OF VAP-1"
Inhibition Activity of the Compound on rhVAP-1 and MAO-A/B from US Patent US11649233: "Halo-allylamine SSAO/VAP-1 inhibitor and use thereof"
Assay data:18 Active, 18 Activity ≤ 1 µM, 18 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Biological Assays of the SSAO Enzyme Inhibitors from US Patent US11530208: "Imidazo[4,5-C]pyridine derived SSAO inhibitors"
Assay data:9 Active, 9 Activity ≤ 1 µM, 9 Tested
Enzyme Activity Assay: from US Patent US11505532: "SSAO inhibitor"
Assay data:81 Active, 51 Activity ≤ 1 nM, 81 Activity ≤ 1 µM, 81 Tested
Time dependent inhibition of human recombinant SSAO assessed as Kinact
Assay data:1 Tested
SummaryPubMed CitationRelated BioAssays by Target
Time dependent inhibition of human recombinant SSAO assessed as inhibition constant
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Inhibition of rat SSAO
Inhibition of SSAO in HMEC cells
Inhibition of recombinant human SSAO
Assay data:10 Active, 10 Activity ≤ 1 µM, 10 Tested
SSAO Activity Assay from US Patent US11472769: "SSAO inhibitors and use thereof"
Assay data:145 Active, 146 Activity ≤ 1 µM, 146 Tested
Biological Assay from US Patent US11396495: "Amine compound for inhibiting SSAO/VAP-1 and use thereof"
Assay data:34 Active, 22 Activity ≤ 1 nM, 34 Activity ≤ 1 µM, 34 Tested
Inhibition Assay from US Patent US11098045: "Haloallylamine indole and azaindole derivative inhibitors of lysyl oxidases and uses thereof"
Assay data:111 Tested
SummaryRelated BioAssays by DepositorRelated BioAssays by Target
Enzyme Activity Assay from US Patent US11001563: "SSAO inhibitor"
Biological Assays from US Patent US10968223: "Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors"
Assay data:155 Active, 155 Activity ≤ 1 µM, 155 Tested
In Vitro Activity Assay from US Patent US10793552: "Amino pyrimidine ssao inhibitors"
Assay data:3 Active, 3 Activity ≤ 1 µM, 3 Tested
Biological Assay from US Patent US10766897: "Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors"
Inhibit Human Recombinant Assay from US Patent US10717734: "Indole and azaindole haloallylamine derivative inhibitors of lysyl oxidases and uses thereof"
Assay data:42 Tested
Inhibit Human Recombinant Assay from US Patent US10717733: "Haloallylamine indole and azaindole derivative inhibitors of lysyl oxidases and uses thereof"
TBD from US Patent US10730850: "Pyridinylmethyl carbamimidoylcarbamate derivatives and their use as AOC3 inhibitors"
Assay data:47 Active, 1 Activity ≤ 1 µM, 106 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on